Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhere
Conditions
Interventions
Intervention1: Cap.NIFAy.C19(CONTAZAP)-640 mg a polyherbal formulation: The composition of NIFAy.C-19 (CONTAZAP) includes aqueous extract of Kalmegh (Andrographis panniculata Nees), Revand Chini (Rheu
Sponsors
National Innovation FoundationIndia
Central Council of Research in Ayurvedic Sciences
Eligibility
Inclusion criteria
Inclusion criteria: 1.Patients tested positive for SARS-CoV2 virus infection 2.Patients having one or more symptoms of mild to moderate category of COVID-19 infection. 3 Patients of either sex. 4.Age: 18 years to 80 years. 5.Patients who can take oral medicines 6.Patients who are ready to give consent to participate in the study.
Exclusion criteria
Exclusion criteria: 1.Patients having severe symptoms of COVID-19 infection. 2.Age below 18 years and more than 80 years. 3.Patients requiring intubation or mechanical ventilators. 4.Pregnant and lactating women. 5.Oncological disease and other systematic un-controlled condition 6.RFT >= 2.5 times of the upper limit. 7.Patients participating in other trial
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| a) Mean time (days) for clinical recovery as per clinical recovery criteria. b) Number of patients showing â??clinical recoveryâ?? Timepoint: a) at baseline, 8th day, 14th day, 21st day (if required) showing â??clinical recoveryâ?? | — |
Secondary
| Measure | Time frame |
|---|---|
| 1.Percentage of patients with negative SARS-CoV-2 on nasal or throat swab in a 2 days continuous RT-PCR test. 2.Improvement in selected laboratory Parameters: CBC, RBS, ESR, Hs-CRP, LDH,S.Ferritin, IL-6, LFT and RFT. 3.No of cases Reporting any ADR/AE 4. Number of participants referred with onset of complications. Timepoint: Baseline- 8 days 15 days | — |
Countries
India
Contacts
Public ContactDr N R Singh
Ch. Brahm Prakash Ayurved Charak Sansthan
Outcome results
None listed